private:juneaubiosciences
|
380995
|
Dec 3rd, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Dec 3rd, 2020 11:08AM
|
Dec 3rd, 2020 11:08AM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Dec 2nd, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Dec 2nd, 2020 01:29PM
|
Dec 2nd, 2020 01:29PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Dec 1st, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Dec 1st, 2020 01:05PM
|
Dec 1st, 2020 01:05PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 30th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 29th, 2020 07:10PM
|
Nov 30th, 2020 01:56PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 28th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 28th, 2020 02:46PM
|
Nov 28th, 2020 02:46PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 27th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 27th, 2020 11:10AM
|
Nov 27th, 2020 11:10AM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 26th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 26th, 2020 12:09PM
|
Nov 26th, 2020 12:09PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 25th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 25th, 2020 05:27PM
|
Nov 25th, 2020 05:27PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 24th, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 24th, 2020 12:40PM
|
Nov 24th, 2020 12:40PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:juneaubiosciences
|
380995
|
Nov 23rd, 2020 12:00AM
|
Juneau Biosciences
|
109
|
11.00
|
Open
|
Research
|
Nov 23rd, 2020 02:45PM
|
Nov 23rd, 2020 02:45PM
|
Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care.
Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions.
Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.
|
Open
|
womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn
|
Open
|
2749 East Parleys Way, Suite 200
|
Salt Lake City
|
UT
|
US
|
84109
|
|
Juneau Biosciences
|
|
Pharmaceuticals & Biotechnology
|